Hwanhee Hong - Publications, H-index & Citations

Hwanhee Hong

Medicine

32H指数

209论文数

4.7K被引数

收录论文 81

发表时间

Comparative effectiveness of antidepressants for depression using EHRs from two health systems 比较来自两个医疗系统的电子健康记录中抗抑郁药治疗抑郁症的疗效

BMC Psychiatry

IF3.6

2026-05-25

OAAI

Hwanhee Hong; Congwen Zhao; Kyungeun Jeon; Elena Badillo Goicoechea; Carly L. Brantner; Grace V. Ringlein; Peter P. Zandi; Jane P. Gagliardi; Fernando S. Goes; Benjamin A. Goldstein; Elizabeth A. Stuart

Trials augmented by external control data using balancing weights: A comparison of estimands and estimators

Contemporary Clinical Trials

IF1.9

2026-01-01

PREAI

Wang, Peijin; Hong, Hwanhee; Jeon, Kyungeun; Thomas, Laine Elliott

Precision mental health: predicting heterogeneous treatment effects for depression through data integration 精准心理健康：通过数据整合预测抑郁症的异质性治疗效果

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS

IF1.3

2025-12-01

PREAI

Brantner, Carly L.; Nguyen, Trang Quynh; Parikh, Harsh; Zhao, Congwen; Hong, Hwanhee; Stuart, Elizabeth A.

Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials 罗卡替利单抗治疗中重度特应性皮炎的疗效与安全性：ROCKET-IGNITE和ROCKET-HORIZON两项全球性、双盲、安慰剂对照、随机III期临床研究

The Lancet

IF97.3

2025-11-25

PREAI

Emma Guttman-Yassky; Kenji Kabashima; Margitta Worm; Paula C Luna; H Chih-Ho Hong; Raj Chovatiya; Jonathan A Bernstein; Johannes S Kern; Benjamin D Ehst; Nina Magnolo; Pedro Herranz-Pinto; Linda Stein Gold; Howard Sofen; Andrew E Pink; Ehsanollah Esfandiari; Takahiro Arai; Yiping Yang; Rebecca Shi; Carolina Barragan; Greg Kricorian

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials 0.3%罗氟司特乳膏在慢性斑块状银屑病患者中的研究：DERMIS III期试验合并的PASI和PASI-HD结果

Dermatology and Therapy

IF4.2

2025-10-24

OAAI

Kim A. Papp; James Q. Del Rosso; Mark G. Lebwohl; Melinda J. Gooderham; Adelaide A. Hebert; H. Chih-ho Hong; Leon H. Kircik; David M. Pariser; Linda Stein Gold; Bruce Strober; Melissa S. Seal; David Krupa; David H. Chu; Patrick Burnett; David R. Berk; Robert C. Higham

Estimating the observability of an outcome from an electronic health record data set using external data 利用外部数据估计电子健康记录数据集中某一结局的可观测性

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2025-10-01

PREAI

Yan, Mengying; Hong, Hwanhee; Wilson, Jonathan; Goldstein, Benjamin A.

The challenges of integrating diverse data sources: A case study in major depression

HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY

IF1.6

2025-10-01

PREAI

Brantner, Carly L.; Yu, Wenshan; Zhao, Congwen; Jeon, Kyungeun; Ringlein, Grace V.; Wang, Qiao; Lemoto, Elaona; Nguyen, Trang Quynh; Gagliardi, Jane P.; Zandi, Peter P.; Goldstein, Benjamin A.; Stuart, Elizabeth A.; Hong, Hwanhee

A Bayesian Re-analysis of the STRESS Trial STRESS试验的贝叶斯再分析

American Heart Journal

IF3.5

2025-09-25

PREAI

Kevin D. Hill; Jake Koerner; Hwanhee Hong; Jennifer S. Li; Christoph Hornik; Prince J. Kannankeril; Jeffrey P. Jacobs; H. Scott Baldwin; Marshall L. Jacobs; Eric M. Graham; Brian Blasiole; David F. Vener; Adil S. Husain; S. Ram Kumar; Alexis Benscoter; Eric Wald; Tara Karamlou; Andrew H Van Bergen; David Overman; Pirooz Eghtesady; Ryan Butts; John S. Kim; John P. Scott; Brett R. Anderson; Michael F. Swartz; Sean M. O’Brien

Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks 乌帕替尼（Upadacitinib）治疗中重度特应性皮炎的疗效与安全性：第3期随机临床试验结果（为期140周）

American Journal of Clinical Dermatology

IF8.8

2025-09-03

OAAI

Alan D. Irvine; Vimal H. Prajapati; Emma Guttman-Yassky; Eric L. Simpson; Kim A. Papp; Andrew Blauvelt; Chia-Yu Chu; H. Chih-ho Hong; Linda F. Stein Gold; Marjolein de Bruin-Weller; Thomas Bieber; Kenji Kabashima; David Rosmarin; Cristina Sancho; Brian M. Calimlim; Ayman Grada; Yang Yang; Xiaoqiang Wu; Gweneth Levy; Eliza M. Raymundo; Henrique D. Teixeira; Jonathan I. Silverberg

Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)Lebrikizumab在成人及青少年患者中治疗中重度特应性皮炎的疗效与安全性：一项安慰剂对照、随机IIIb期临床试验（ADvantage）

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-09-01

PREAI

Warren, Richard B.; de Bruin-Weller, Marjolein; Tsianakas, Athanasios; Khemis, Abdallah; Szepietowski, Jacek C.; Hong, H. Chih-ho; Mihaylov, Yanislav; Falques, Meritxell; Agell, Helena; Massana, Eric; Gil, Esther Garcia; Coll, Ruth; Weidinger, Stephan

Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16 临床上有意义的改善：在未于第16周达到皮肤清除或近乎清除的中度至重度特应性皮炎青少年患者中使用Tralokinumab治疗的情况

Dermatology and Therapy

IF4.2

2025-07-28

OAAI

Amy S. Paller; Andrew Blauvelt; Weily Soong; H. Chih-ho Hong; Marie L. A. Schuttelaar; Shannon K. R. Schneider; Eric L. Simpson

Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis Lebrikizumab可改善中重度特应性皮炎患者的头/颈/面部皮炎和红斑，且不会增加治疗 emergent 的头/颈/面部红斑相关不良事件。

Journal of Dermatological Treatment

IF3.9

2025-07-24

OAAI

Jenny E. Murase; Kilian Eyerich; Raj Chovatiya; H. Chih-ho Hong; Christine Bangert; Lindsay Strowd; Mette Deleuran; Amber Reck Atwater; Maria Jose Rueda; Hany Elmaraghy; Maria Lucia Buziqui Piruzeli; Ignasi Pau-Charles; Fan Emily Yang; Jinglin Zhong; Delphine Staumont-Sallé

Lebrikizumab improves quality of life and wellbeing of patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin: German extension results (week 76) of the ADvantage study lebrikizumab改善了使用环孢素控制不佳或不适合使用环孢素的轻中度特应性皮炎患者的生命质量和幸福感：ADvantage研究德国扩展研究结果（第76周）。

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-07-01

OAAI

Warren, Richard B.; de Bruin-Weller, Marjolein; Tsianakas, Athanasios; Khemis, Abdallah; Szepietowski, Jacek C.; Hong, H. Chih-Ho; Gil, Esther Garcia; Mihaylov, Yanislav; Falques, Meritxell; Agell, Helena; Weidinger, Stephan

Lebrikizumab improves quality of life in patients with moderate-to-severe atopic dermatitis inadequately controlled or ineligible for ciclosporin (ADvantage study)Lebrikizumab改善了不适合或无法使用环孢素治疗的轻至重度特应性皮炎患者的生活质量（ADvantage研究）

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-07-01

OAAI

Warren, Richard B.; de Bruin-Weller, Marjolein; Tsianakas, Athanasios; Khemis, Abdallah; Szepietowski, Jacek C.; Hong, H. Chih-Ho; Valls, Julia; Sapena, Victor; Agell, Helena; Massana, Eric; Gil, Esther Garcia; Weidinger, Stephan

Canadian Consensus Guidelines for the Management of Vitiligo

DERMATOLOGY AND THERAPY

IF4.2

2025-04-01

OAAI

Prajapati, Vimal H.; Lui, Harvey; Miller-Monthrope, Yvette; Ringuet, Julien; Turchin, Irina; Hong, H. Chih-ho; Lynde, Charles; Papp, Kim A.; Yeung, Jensen; Gooderham, Melinda J.

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial

DERMATITIS

IF3.2

2025-01-10

PREAI

Simpson, Eric L.; Eichenfield, Lawrence F.; Papp, Kim A.; Forman, Seth B.; Hebert, Adelaide A.; Gonzalez, Mercedes E.; Gooderham, Melinda J.; Hong, H. Chih-ho; Prajapati, Vimal H.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Seal, Melissa S.; Krupa, David; Almaraz, Erin; Hanna, Diane; Burnett, Patrick; Snyder, Scott; Chu, David H.; Higham, Robert C.; Berk, David R.

The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2024-12-01

PREAI

Guttman-Yassky, Emma; Rosmarin, David; de Bruin-Weller, Marjolein; Weidinger, Stephan; Bieber, Thomas; Hong, H. Chih-ho; Elmaraghy, Hany; Atwater, Amber Reck; Pierce, Evangeline; Xu, Chenjia; Agell, Helena; Gil, Esther Garcia; Simpson, Eric

Bayesian re-analysis of the STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS) trial STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS)试验的贝叶斯再分析

CIRCULATION

IF38.6

2024-11-12

PREAI

Hill, Kevin; Koerner, Jake; Hong, Hwanhee; Li, Jennifer; Jacobs, Marshall; Kannankeril, Prince; Baldwin, Scott; Jacobs, Jeffrey; Hornik, Christoph; Benscoter, Alexis; Van Bergen, Andrew; Anderson, Brett; Blasiole, Brian; Overman, David; Vener, David; Graham, Eric; Husain, Adil; Wald, Eric; Scott, John; Kim, John; Swartz, Michael; Eghtesady, Pirooz; Butts, Ryan; Karamlou, Tara; OBrien, Sean

Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-10-23

OAAI

Silverberg, Jonathan, I; Bunick, Christopher G.; Hong, H. Chih-ho; Mendes-Bastos, Pedro; Gold, Linda Stein; Costanzo, Antonio; Ibrahim, Nadia; Sancho, Cristina; Wu, Xiaoqiang; Han, Yu; Levy, Gweneth; Altman, Kathy; Calimlim, Brian; Eyerich, Kilian

Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Simpson, Eric L.; Eichenfield, Lawrence F.; Papp, Kim A.; Forman, Seth; Hebert, Adelaide A.; Gonzalez, Mercedes E.; Gooderham, Melinda; Hong, H. Chih-ho; Prajapati, Vimal H.; Guttman, Emma; Silverberg, Jonathan; Seal, Melissa; Krupa, David; Burnett, Patrick; Synder, Scott; Chu, David H.; Higham, Robert C.; Berk, David R.

研究方向